Nikko Asset Management Americas’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Sell |
|
|||||
|
2025
Q1 | $11.2M | Sell |
|
|||||
|
2024
Q4 | $18.4M | Sell |
|
|||||
|
2024
Q3 | $20.1M | Sell |
|
|||||
|
2024
Q2 | $17.2M | Sell |
|
|||||
|
2024
Q1 | $48M | Sell |
|
|||||
|
2023
Q4 | $130M | Sell |
|
|||||
|
2023
Q3 | $112M | Sell |
|
|||||
|
2023
Q2 | $181M | Sell |
|
|||||
|
2023
Q1 | $159M | Sell |
|
|||||
|
2022
Q4 | $116M | Sell |
|
|||||
|
2022
Q3 | $84.5M | Buy |
|
|||||
|
2022
Q2 | $61M | Buy |
|
|||||
|
2022
Q1 | $128M | Buy |
|
|||||
|
2021
Q4 | $245M | Buy |
|
|||||
|
2021
Q3 | $236M | Buy |
|
|||||
|
2021
Q2 | $284M | Buy |
|
|||||
|
2021
Q1 | $175M | Buy |
|
|||||
|
2020
Q4 | $130M | Buy |
|
|||||
|
2020
Q3 | $41.2M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $36K | Buy |
|